 TEL AVIV, Israel and BETHESDA, Md., May 25, 2021 PRNewswire -- Cannabics Pharmaceuticals Inc. OTCQB: CNBX, a global leader in the development of cancer related cannabinoid-based medicine, announced today that the companys patent titled: System and Method for High Throughput Screening of Cancer Cells has been granted by the European Patent Office. 